When patients and their families leave the emergency room, they’re usually clutching a sheaf of papers: Called discharge notes, they contain important instructions about how
In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence. AI could accelerate the pace of new
When the murder of George Floyd in 2020 ignited calls for racial equity across the U.S., the field of medicine confronted its own thorny questions
Senators led by Sen. Dick Durbin (D-Ill.) on Monday demanded answers from Pfizer and Eli Lilly about their relationship with the telehealth prescribers they point
Jazmin Evans was waiting on dialysis for four years before finally, on the Fourth of July last year, she received a kidney transplant. “Now I
In the last two years, telehealth has gone all in on GLP-1s. Dozens of companies have started to offer the wildly popular obesity and diabetes
In the early days of the Covid-19 pandemic, hospitals were desperate for ways to manage the flood of seriously ill patients. Many turned to an
The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound
In the last year, pharma incumbents have leaned into partnerships with AI-driven startups to supercharge drug discovery efforts. High-powered models of protein structure and molecule
At last count, the Food and Drug Administration has authorized 950 medical devices that use artificial intelligence and machine learning. But far fewer have made